tremfya
janssen-cilag international nv - guselkumab - psoriaza - imunosupresivi - plaque psoriasis tremfya is indicated for the treatment of moderate to severe plaque psoriasis in adults who are candidates for systemic therapy. psoriatic arthritis tremfya, alone or in combination with methotrexate (mtx), is indicated for the treatment of active psoriatic arthritis in adult patients who have had an inadequate response or who have been intolerant to a prior disease-modifying antirheumatic drug (dmard) therapy (see section 5.
tremfya 100 mg raztopina za injiciranje
janssen-cilag international nv - guselkumab - raztopina za injiciranje - guselkumab 100 mg / 1 brizga - guselkumab
taltz 80 mg raztopina za injiciranje v napolnjenem injekcijskem peresniku
eli lilly nederland bv - iksekizumab - raztopina za injiciranje - iksekizumab 80 mg / 1 peresnik - iksekizumab
taltz 80 mg raztopina za injiciranje v napolnjenem injekcijskem peresniku
eli lilly nederland bv - iksekizumab - raztopina za injiciranje - iksekizumab 80 mg / 1 peresnik - iksekizumab
taltz 80 mg raztopina za injiciranje v napolnjenem injekcijskem peresniku
eli lilly nederland bv - iksekizumab - raztopina za injiciranje - iksekizumab 80 mg / 1 peresnik - iksekizumab
taltz 80 mg raztopina za injiciranje v napolnjeni injekcijski brizgi
eli lilly nederland bv - iksekizumab - raztopina za injiciranje - iksekizumab 80 mg / 1 brizga - iksekizumab
taltz 80 mg raztopina za injiciranje v napolnjeni injekcijski brizgi
eli lilly nederland bv - iksekizumab - raztopina za injiciranje - iksekizumab 80 mg / 1 brizga - iksekizumab
taltz 80 mg raztopina za injiciranje v napolnjeni injekcijski brizgi
eli lilly nederland bv - iksekizumab - raztopina za injiciranje - iksekizumab 80 mg / 1 brizga - iksekizumab
taltz
eli lilly and company (ireland) limited - ixekizumab - psoriaza - imunosupresivi - plaketo psoriasistaltz je primerna za zdravljenje zmerno do hudo psoriazo v plakih pri odraslih, ki so kandidati za sistemsko terapijo. psoriatični arthritistaltz, samostojno ali v kombinaciji z metotreksatom, je primerna za zdravljenje aktivnega psoriatičnega artritisa pri odraslih bolnikih, ki so se odzvali neustrezno ali ki so nestrpni do enega ali več bolezni spreminjajo anti-revmatičnih drog (dmard) terapije.
spevigo
boehringer ingelheim international gmbh - spesolimab - psoriaza - imunosupresivi - spevigo is indicated for the treatment of flares in adult patients with generalised pustular psoriasis (gpp) as monotherapy.